Panaxydol and Panaxynol Protect Cultured Cortical Neurons Against Aβ25–35-induced Toxicity

Bao-Ming Nie,Xiao-Yan Jiang,Jin-Xian Cai,Sai-Li Fu,Li-Min Yang,Lin,Qin Hang,Pei-Lua Lu,Yang Lu
DOI: https://doi.org/10.1016/j.neuropharm.2008.01.003
IF: 5.273
2008-01-01
Neuropharmacology
Abstract:Amyloid β protein (Aβ), the central constituent of senile plaques in Alzheimer's disease (AD), is known to exert toxic effects on cultured neurons. In the present study, the protective effect of panaxydol (PND) and panaxynol (PNN) on Aβ25–35-induced neuronal apoptosis and potential mechanisms were investigated in primary cultured rat cortical neurons. Pretreatment of the cells with PND or PNN prior to 10μM Aβ25–35 exposure resulted significantly in elevation of cell survival determined by MTT assay, TUNEL/Hoechst staining and western blot. Furthermore, a marked increase in calcium influx and intracellular free radical generation was found after Aβ25–35 exposure, which could be almost completely reversed by pretreatment of PND or PNN. PND and PNN could also alleviate Aβ25–35-induced early-stage neuronal degeneration. These results indicated that inhibition of calcium influx and free radical generation is a mechanism of the anti-apoptotic action of PND and PNN. Since Aβ plays critical roles in the pathogenesis of AD, these findings raise the possibility that PND and PNN reduce neurodegeneration in AD.
What problem does this paper attempt to address?